You are here

NSC Treatment Feasible for Motor Stroke

A recent STEM CELLS Translational Medicine article reports the findings of a single‐site, phase I study of the transplantation of human neural stem cells (NSCs) for the treatment of hemiparesis due to chronic motor stroke. Researchers from the labs of Karl K. Johe (Neuralstem Inc., Germantown, Maryland, USA) and Xu Ruxiang (Army General Hospital of PLA, Beijing, China) provide evidence of stable allogeneic neural tissue formation by the stem cells in the brains of chronic stroke patients, suggesting statistically significant clinical benefits from baseline as measured by three different validated stroke scales.